Stocks › TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
TEVA·NYSE·USD
$39.13
-0.53 (-1.34%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD · NYSE
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
TEVAS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of TEVA by members of U.S. Congress · 30 on record · 1 in the last 12 months
Whale Activity
Position changes in TEVA reported for 2026-09-30 by 1 tracked institutional filer
- Increased0
- New0
- Held0
- Decreased0
- Closed1
- No prior filing0
| Filer | Shares | Value | Change |
|---|---|---|---|
| Parrish Capital LLC | 0 | $0 | closed |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by TEVA insiders, by quarter · Form 4
Recent Insider Transactions
783 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| Savage BrianInterim Chief Legal Officer | Sale | −4,503 | $38.69 | $174K | Sep 18, 2026 | Form 4 ↗ |
| Savage BrianInterim Chief Legal Officer | Sale | −314 | $38.70 | $12K | Sep 18, 2026 | Form 4 ↗ |
| Savage BrianInterim Chief Legal Officer | Sale | −2,525 | $39.15 | $99K | Sep 18, 2026 | Form 4 ↗ |
| MIGNONE ROBERTODirector · Director | Sale | −367.6K | $39.06 | $14.4M | Sep 18, 2026 | Form 4 ↗ |
| Weiss AmirChief Accounting Officer | Sale | −6,945 | $37.61 | $261K | Aug 21, 2026 | Form 4 ↗ |
| Weiss AmirChief Accounting Officer | Sale | −2,500 | $37.63 | $94K | Aug 21, 2026 | Form 4 ↗ |
| Satchi-Fainaro RonitDirector · Director | Sale | −415 | $37.25 | $15K | Aug 21, 2026 | Form 4 ↗ |
| Lippman EvanEVP, Business Development | Sale | −18.6K | $36.57 | $680K | Aug 17, 2026 | Form 4 ↗ |
| Zaks Tal ZviDirector · Director | Sale | −17 | $34.87 | $593 | Aug 5, 2026 | Form 4 ↗ |
| Jover PlacidSee "Remarks" | Sale | −12.8K | $34.88 | $447K | Aug 3, 2026 | Form 4 ↗ |
| Hughes Eric ASee "Remarks" | Sale | −25.6K | $34.88 | $892K | Aug 3, 2026 | Form 4 ↗ |
| Shields MatthewEVP, Global Operations | Sale | −9,989 | $32.19 | $322K | Jun 18, 2026 | Form 4 ↗ |
| Kalif Eliyahu SharonEVP, Chief Financial Officer | Sale | −106.6K | $34.10 | $3.6M | Jun 11, 2026 | Form 4 ↗ |
| BARER SOL JDirector | Option exercise | +21.7K | — | — | Jun 5, 2026 | Form 4 ↗ |
| Lichtenstein ChenDirector | Option exercise | +14.5K | — | — | Jun 5, 2026 | Form 4 ↗ |
| Crane Rosemary ADirector | Option exercise | +14.5K | — | — | Jun 5, 2026 | Form 4 ↗ |
| Elstein AmirDirector | Option exercise | +14.5K | — | — | Jun 5, 2026 | Form 4 ↗ |
| LIEBERMAN GERALD MDirector | Option exercise | +14.5K | — | — | Jun 5, 2026 | Form 4 ↗ |
| Nisen PerryDirector | Option exercise | +14.5K | — | — | Jun 5, 2026 | Form 4 ↗ |
| Satchi-Fainaro RonitDirector | Option exercise | +14.5K | — | — | Jun 5, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding TEVA · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| WCM Focused International Growth Fund INVESTMENT MANAGERS SERIES TRUST | 13.3M | $449.0M | 2.00% | Jun 30, 2026 |
| iShares Core MSCI EAFE ETF iShares Trust | 8.7M | $304.0M | 0.16% | Jul 31, 2026 |
| New Economy Fund | 7.7M | $272.5M | 0.53% | May 31, 2026 |
| Fidelity International Index Fund Fidelity Concord Street Trust | 4.3M | $152.4M | 0.18% | May 31, 2026 |
| New World Fund Inc | 4.3M | $150.8M | 0.17% | Jul 31, 2026 |
| iShares MSCI EAFE ETF iShares Trust | 4.1M | $144.2M | 0.18% | Jul 31, 2026 |
| Fidelity Contrafund | 3.6M | $122.8M | 0.07% | Jun 30, 2026 |
| Strategic Advisers Fidelity International Fund Fidelity Rutland Square Trust II | 3.2M | $113.9M | 0.16% | May 31, 2026 |
| BlackRock Health Sciences Opportunities Portfolio BlackRock Funds | 3.1M | $110.2M | 1.87% | May 29, 2026 |
| Old Westbury Large Cap Strategies Fund Old Westbury Funds Inc | 2.8M | $96.9M | 0.38% | Jul 31, 2026 |
Mutual funds and ETFs whose N-PORT filings list TEVA's shares (CUSIP 881624209), each fund at its latest report since Mar 7, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
No 13D/13G beneficial-ownership filings on record.
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming TEVA PHARMACEUTICAL INDUSTRIES LTD as client
No lobbying filings found naming TEVA PHARMACEUTICAL INDUSTRIES LTD as the client.
Government Contracts
Federal awards to TEVA PHARMACEUTICAL INDUSTRIES LTD · USAspending
No federal contract awards found for TEVA PHARMACEUTICAL INDUSTRIES LTD.
U.S. Patents
Recent USPTO applications naming TEVA PHARMACEUTICAL INDUSTRIES LTD
No USPTO patent applications found for TEVA PHARMACEUTICAL INDUSTRIES LTD.
Annual Financials
From TEVA's 10-K filings · XBRL
No annual XBRL figures on record for TEVA. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
- 2-for-1Stock splitJul 1, 2004
- 2-for-1Stock splitDec 6, 2002
- 2-for-1Stock splitFeb 23, 2000
- 2-for-1Stock splitApr 14, 1993
Split dates and ratios from the price history · Close Prices from Tiingo.com
Material Events (8-K)
Corporate events filed with the SEC
- 8-K · Items 1.01, 2.03, 9.01Material agreement · Direct financial obligationSep 16, 2026
EDGAR ↗ - 8-K · Items 8.01Other eventsSep 14, 2026
EDGAR ↗ - 8-K · Items 7.01, 8.01, 9.01Reg FD disclosure · Other eventsSep 11, 2026
EDGAR ↗ - 8-K · Items 8.01, 9.01Other eventsSep 3, 2026
EDGAR ↗ - 8-K · Items 3.03, 9.01Modification of rightsSep 3, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsJul 29, 2026
EDGAR ↗ - 8-K · Items 5.07Shareholder voteMay 28, 2026
EDGAR ↗
About TEVA PHARMACEUTICAL INDUSTRIES LTD
From SEC EDGAR company records
Industry (SIC 2834)Pharmaceutical Preparations
SectorHealthcare
HeadquartersTEL AVIV
IncorporatedL3
SEC CIK0000818686 ↗
Former namesTEVA PHARMACEUTICAL INDUSTRIES LIMITED